18787084

Source:http://linkedlifedata.com/resource/pubmed/id/18787084

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027396, umls-concept:C0035647, umls-concept:C0059865, umls-concept:C0085155, umls-concept:C0086027, umls-concept:C0155626, umls-concept:C0205217, umls-concept:C1546805, umls-concept:C1565860, umls-concept:C1705323, umls-concept:C1707455, umls-concept:C1999216, umls-concept:C2348984
pubmed:issue	4
pubmed:dateCreated	2008-12-17
pubmed:abstractText	This study compares the risk of acute myocardial infarction among patients exposed to etodolac, naproxen, celecoxib, and rofecoxib.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602617
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Generic, http://linkedlifedata.com/resource/pubmed/chemical/Etodolac, http://linkedlifedata.com/resource/pubmed/chemical/Lactones, http://linkedlifedata.com/resource/pubmed/chemical/Naproxen, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/Sulfones, http://linkedlifedata.com/resource/pubmed/chemical/celecoxib, http://linkedlifedata.com/resource/pubmed/chemical/rofecoxib
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1074-2484
pubmed:author	pubmed-author:BanerjeeSubhashS, pubmed-author:BrilakisEmmanouil SES, pubmed-author:CryerByronB, pubmed-author:CunninghamFrancescaF, pubmed-author:HarfordWilliam VWV, pubmed-author:KaziSalahuddinS, pubmed-author:KellyKevin CKC, pubmed-author:LittleBertis BBB, pubmed-author:WarnerJohn JJJ, pubmed-author:WeidemanRick ARA
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	252-60
pubmed:meshHeading	pubmed-meshheading:18787084-Aged, pubmed-meshheading:18787084-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:18787084-Cohort Studies, pubmed-meshheading:18787084-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:18787084-Drug Utilization Review, pubmed-meshheading:18787084-Drugs, Generic, pubmed-meshheading:18787084-Etodolac, pubmed-meshheading:18787084-Humans, pubmed-meshheading:18787084-Incidence, pubmed-meshheading:18787084-Lactones, pubmed-meshheading:18787084-Male, pubmed-meshheading:18787084-Medical Records, pubmed-meshheading:18787084-Middle Aged, pubmed-meshheading:18787084-Myocardial Infarction, pubmed-meshheading:18787084-Naproxen, pubmed-meshheading:18787084-Prevalence, pubmed-meshheading:18787084-Prognosis, pubmed-meshheading:18787084-Pyrazoles, pubmed-meshheading:18787084-Retrospective Studies, pubmed-meshheading:18787084-Risk Assessment, pubmed-meshheading:18787084-Risk Factors, pubmed-meshheading:18787084-Sulfonamides, pubmed-meshheading:18787084-Sulfones, pubmed-meshheading:18787084-Texas, pubmed-meshheading:18787084-Veterans
pubmed:year	2008
pubmed:articleTitle	The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
pubmed:affiliation	Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas 75390, USA. john.warner@utsouthwestern.edu
pubmed:publicationType	Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S.